Onyx Pharmaceuticals, Eli Lilly deal

The companies extended and expanded their May 1995 research alliance, which focuses on BRCA1, a tumor suppressor gene linked to susceptibility to breast and ovarian cancers. The collaboration aims to understand the role of BRCA1-related pathways in breast cancer and to identify proteins that interact with BRCA1 that could be used to develop therapeutics. ...